Who owns Elicio Therapeutics Inc Com?
- Ticker: ELTX
- CUSIP Number: 28657f103
Tip: Access positions for across all investors
Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elicio Therapeutics stock
Who bought or sold Elicio Therapeutics Inc Com this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Knoll Capital Management | 1.2M | $4.7M | 92% | Jun 2026 |
|
| BlackRock | 766k | $3.0M | 1414% | Jun 2026 |
|
| Caption Management | 584k | $2.3M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 572k | $2.2M | 10% | Jun 2026 |
|
| Ikarian Capital | 314k | $1.2M | 100% | Jun 2026 |
|
| Geode Capital Management | 311k | $1.2M | 130% | Jun 2026 |
|
| Susquehanna International | 272k | $1.1M | -27% | Jun 2026 |
|
| Diadema Partners | 212k | $829k | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 200k | $782k | 100% | Jun 2026 |
|
| Jane Street | 186k | $727k | 61% | Jun 2026 |
|
| Citadel Advisors | 149k | $583k | 91% | Jun 2026 |
|
| Northern Trust | 130k | $509k | 118% | Jun 2026 |
|
| Boothbay Fund Management | 96k | $373k | 100% | Jun 2026 |
|
| Vanguard Portfolio Management | 89k | $348k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 88k | $344k | 27% | Jun 2026 |
|
| Alliancebernstein | 81k | $318k | 100% | Jun 2026 |
|
| State Street Corporation | 51k | $541k | 9% | Mar 2026 |
|
| UBS Group | 40k | $158k | 20% | Jun 2026 |
|
| Morgan Stanley | 32k | $346k | 123% | Mar 2026 |
|
| Charles Schwab Investment Management | 32k | $124k | 100% | Jun 2026 |
|
| Sixth Street Partners Management Company | 32k | $124k | 100% | Jun 2026 |
|
| Leonteq Securities | 20k | $78k | 100% | Jun 2026 |
|
| Nuveen | 18k | $70k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 16k | $62k | 100% | Jun 2026 |
|
| New York State Common Retirement Fund | 14k | $56k | 100% | Jun 2026 |
|
| Meyer Handelman | 14k | $54k | 0% | Jun 2026 |
|
| HighTower Advisors | 14k | $53k | 22% | Jun 2026 |
|
| Raymond James Financial | 13k | $50k | 15% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $50k | 100% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 12k | $42k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 12k | $47k | 100% | Jun 2026 |
|
| HB Wealth Management | 11k | $41k | 0% | Jun 2026 |
|
| Summit Financial | 10k | $39k | 0% | Jun 2026 |
|
| Mayflower Financial Advisors | 10k | $39k | 0% | Jun 2026 |
|
| Moody Lynn & Co/ | 10k | $39k | 0% | Jun 2026 |
|
| Wiley Bros.-aintree Capital | 10k | $39k | 0% | Jun 2026 |
|
| Rhumbline Advisers | 6.7k | $26k | 100% | Jun 2026 |
|
| Mirae Asset Global Etfs Holdings | 6.0k | $23k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 5.4k | $22k | 100% | Jun 2026 |
|
| Tower Research Capital | 5.3k | $21k | 528500% | Jun 2026 |
|
| Vanguard Global Advisers | 4.4k | $17k | 0% | Jun 2026 |
|
| Mercer Global Advisors | 3.2k | $13k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.1k | $8.1k | -67% | Jun 2026 |
|
| Steward Partners Investment Advisory | 2.0k | $7.9k | 0% | Jun 2026 |
|
| Barclays | 1.8k | $6.9k | 100% | Jun 2026 |
|
| Legal & General Group | 1.3k | $5.2k | 100% | Jun 2026 |
|
| Summit Investment Advisors | 1.2k | $4.6k | 100% | Jun 2026 |
|
| Russell Investments | 1.0k | $4.0k | 100% | Jun 2026 |
|
| Farther Finance Advisors | 947.00 | $3.7k | 31% | Jun 2026 |
|
| Persistent Asset Partners | 541.00 | $38k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 443.00 | $2.0k | 1826% | Jun 2026 |
|
| SBI Securities | 183.00 | $716.005800 | 123% | Jun 2026 |
|
| FMR | 124.00 | $485.001200 | 100% | Jun 2026 |
|
| National Bank Of Canada /fi/ | 100.00 | $391.000000 | 100% | Jun 2026 |
|
| Sterling Capital Management | 46.00 | $179.998000 | 100% | Jun 2026 |
|
Who sold out of Elicio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Balyasny Asset Management | Mar 2026 | 245k | $2.6M |
| Renaissance Technologies | Mar 2026 | 122k | $1.3M |
| Millennium Management | Mar 2026 | 93k | $992k |
| Marshall Wace | Mar 2026 | 75k | $797k |
| Goldman Sachs Group | Mar 2026 | 58k | $618k |
| 683 Capital Management | Mar 2026 | 56k | $603k |
| Iridian Asset Management | Mar 2026 | 30k | $321k |
| CM Management | Mar 2026 | 25k | $267k |
| Hrt Financial | Mar 2026 | 22k | $231k |
| Hudson Bay Capital Management | Mar 2026 | 20k | $216k |
| Brevan Howard Capital Management | Mar 2026 | 17k | $186k |
| Quadrature Capital | Mar 2026 | 17k | $181k |
| Bank of America Corporation | Mar 2026 | 15k | $164k |
| Kingswood Wealth Advisors | Mar 2026 | 14k | $148k |
| XTX Topco | Mar 2026 | 14k | $147k |
| Engineers Gate Manager | Mar 2026 | 13k | $141k |
| Qube Research & Technologies | Mar 2026 | 13k | $133k |
| Sio Capital Management | Mar 2026 | 12k | $125k |
| Cresset Asset Management | Mar 2026 | 11k | $122k |
| OMERS Administration Corporation | Mar 2026 | 11k | $114k |
| EFG International | Mar 2026 | 2.2k | $24k |